Basis: Four-quarter free cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The free cash flow yield is N/A as of 2026-10-06T16:57:06.579Z.
Calculation as of: 2026-10-06T16:57:06.579Z.
Quote observation: 2026-10-06T16:55:21.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 80f889fb03c5e90f23e6dbb960addb407f240d79d9565bd54dedfb6815f2f0ce
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
FREE CASH FLOW YIELD
N/A
Heartflow, Inc. Common Stock
Market Cap
$4.43B
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$4.41B
Free Cash Flow Yield
N/A
TTM Avg
5.69%
3Y Avg
5.69%
5Y Avg
5.69%
Market Cap
$4.40B
Free Cash Flow Yield
N/A
TTM Avg
4.72%
3Y Avg
3.77%
5Y Avg
4.33%
Market Cap
$4.28B
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$4.63B
Free Cash Flow Yield
0.72%
TTM Avg
0.53%
3Y Avg
0.53%
5Y Avg
0.53%
Market Cap
$4.66B
Free Cash Flow Yield
N/A
TTM Avg
5.99%
3Y Avg
5.19%
5Y Avg
4.45%
Market Cap
$4.66B
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$4.67B
Free Cash Flow Yield
3.72%
TTM Avg
4.28%
3Y Avg
3.98%
5Y Avg
3.98%
| NAME | MARKET CAP | FREE CASH FLOW YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Heartflow, Inc. Common Stock (HTFL) | $4.43B | N/A | N/A | N/A | N/A |
| Adaptive Biotechnologies Corporation (ADPT)vs › | $4.41B | N/A | 5.69% | 5.69% | 5.69% |
| Indivior Pharmaceuticals Inc (INDV)vs › | $4.40B | N/A | 4.72% | 3.77% | 4.33% |
| Edgewise Therapeutics, Inc. (EWTX)vs › | $4.28B | N/A | N/A | N/A | N/A |
| BillionToOne, Inc. (BLLN)vs › | $4.63B | 0.72% | 0.53% | 0.53% | 0.53% |
| Option Care Health, Inc. (OPCH)vs › | $4.66B | N/A | 5.99% | 5.19% | 4.45% |
| Definium Therapeutics, Inc. (DFTX)vs › | $4.66B | N/A | N/A | N/A | N/A |
| LivaNova PLC (LIVN)vs › | $4.15B | 3.58% | 4.63% | 3.69% | 2.93% |
| LifeStance Health Group, Inc. (LFST)vs › | $4.67B | 3.72% | 4.28% | 3.98% | 3.98% |
| Dianthus Therapeutics, Inc. (DNTH)vs › | $4.71B | N/A | N/A | N/A | N/A |
FCF Yield
N/A
Earnings Yield
N/A
Dividend Yield
N/A
Formula: FCF Yield = (Free Cash Flow / Market Cap) × 100
How FCF Yield is used:
FCF vs earnings: Differences between FCF yield and earnings yield can reflect capital expenditures, working capital changes, and other non-cash accounting items.
FCF Yield measures free cash flow relative to market capitalization. It compares cash generation after capital expenditures with the equity value of the company.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
